ACR News
Coil Surgery Helps Uncontrollable Epistaxis
NEW YORK (Reuters Health) - A small study suggests that placement of platinum fibered coils in the distal internal maxillary artery may put a stop to nosebleeds that won't stop any other way.
Patients Without Typical Appendicitis Signs but Positive CT May Still Need Surgery
NEW YORK (Reuters Health) - Don't see typical clinical signs of appendicitis? Better check that computerized tomography (CT) scan before sending your patient home, according to a new study.
MR Amniotic Fluid Spectroscopy Assesses Late Gestational Age
NEW YORK (Reuters Health) - Magnetic resonance spectroscopy (MRS) of amniotic fluid samples, coupled with statistical modeling, can determine gestational age in the late second and third trimesters, new research shows.
Coronary CT Angiography Valuable in Asymptomatic Patients, Safer Than Ever
NEW YORK (Reuters Health) - In patients with elevated cardiac risk but without cardiac symptoms, coronary computed tomographic angiography (CCTA) can reliably predict cardiac events and assess cardiovascular risk, German researchers reported online April 30 in the American Journal of Cardiology.
ACR Names New Officers: John A. Patti, MD, Elected Chair of the ACR Board of Chancellors
John A. Patti, MD, FACR of Boston, MA, has been elected chair of the ACR Board of Chancellors. Dr. Patti officially took office during the ACR 87th Annual Meeting and Chapter Leadership Conference, held in Washington, DC, May 15-19, 2010. He will serve as chair from May 2010 to May 2011, and thereafter will be eligible to be re-elected for an additional year. In addition, Paul H. Ellenbogen, MD, FACR, was elected to serve as ACR Vice Chair, while James H. Thrall, MD, FACR, was elected to serve as ACR president. Lawrence P. Davis, MD, FACR, will now serve as vice president of the ACR, while Anne C. Roberts, MD, FACR, is now ACR Secretary-Treasurer.
ACR Quality and Safety Lead Featured in Advanced Imaging Accreditation Podcast
Developed by the ACR Committee on Drugs and Contrast Media, the ACR Manual on Contrast Media, Version 7, contains the most current information to guide radiologists to safely and effectively use contrast media in daily medical practice. Suggestions for patient screening, premedication, recognition of adverse reactions, and emergency treatment of such reactions are emphasized.
Early Reperfusion in Acute MI Affects V-Tachycardia Characteristics
NEW YORK (Reuters Health) - Patterns of ventricular tachycardia (VT) differ years later between patients who had early reperfusion of acute myocardial infarction (AMI) and those who didn't, Dutch researchers say.
CT Coronary Angiography Most Helpful for Intermediate-Risk Patients
NEW YORK (Reuters Health) - Computed tomography coronary angiography (CTCA) is most usefully applied in patients with intermediate risk for disease, because it will identify the ones who need more invasive testing, study findings suggest.
Ultrasound Screening, Transfusion Cut Strokes in Sickle Cell Children
NEW YORK (Reuters Health) - Transcranial Doppler screening and prophylactic transfusions have cut the incidence of overt stroke in sickle cell disease more than tenfold, according to researchers at The Children's Hospital of Philadelphia.
AMCLC Daily Wrap Up: Sunday, May 16, 2010
Health-care reform legislation, the MIPPA mandate for accreditation, ever-increasing costs and decreasing reimbursement, reducing radiation dose, and the USPSTF’s recommendations on screening mammography, among others, topped the list of major issues that will be discussed at the 87th AMCLC in Washington, DC.
ACR Manual on Contrast Media, Version 7 Now Available on the ACR Website
Developed by the ACR Committee on Drugs and Contrast Media, the ACR Manual on Contrast Media, Version 7, contains the most current information to guide radiologists to safely and effectively use contrast media in daily medical practice. Suggestions for patient screening, premedication, recognition of adverse reactions, and emergency treatment of such reactions are emphasized.
Ultrasound Plus AFP Can Replace CT/MRI Screening for Liver Cancer
NEW YORK (Reuters Health) - Patients with cirrhosis can be screened for hepatocellular carcinoma (HCC) with ultrasound imaging plus alfa fetoprotein (AFP) levels, instead of more expensive imaging studies, according to data presented Sunday at Digestive Disease Week.
Mammograms Catch Few Cancers in Young Women: Study
WASHINGTON (Reuters) - Mammograms detect few cancers in women under the age of 40 but cause expense and anxiety because women frequently get "false positives" that require follow-up to rule out cancer, researchers reported on Monday.
Daily News Briefing From ARRS 2010 Annual Meeting in San Diego, CA
On Monday, researchers attending the ARRS 2010 Annual Meeting in San Diego, CA, presented several important studies regarding the radiation dose associated with CT scans, radiation safety, and breast imaging.
RadiologyInfo.org Unveils New Look
Commemorating 10 years of growth in content, features and online visitors, RadiologyInfo.org, the public information Web site co-sponsored by the Radiological Society of North America (RSNA) and the American College of Radiology (ACR), announces the launch of a refreshed and reorganized site.
Lung Cancer Screening Often Yields False Positives
NEW YORK (Reuters Health) - Imaging tests used to screen patients for lung cancer often reveal incidental lesions that turn out to not be cancer, according to a U.S. government study published Monday.
PET Not Useful Right After Chemo for Colorectal Liver Metastases
NEW YORK (Reuters Health) - Positron emission tomography (PET) of the liver is extremely unreliable in patients who've just had chemotherapy for colorectal cancer metastases, because the false-negative rate is very high, according to a study from The University of Texas M.D. Anderson Cancer Center.
Gene Linked to Obesity and Higher Alzheimer's Risk
CHICAGO (Reuters) - A variant of an obesity gene carried by more than a third of the U.S. population also reduces brain volume, raising carriers' risk of Alzheimer's disease, U.S. researchers said on Monday.
Test Predicts Who Shouldn't Take Colon Cancer Drug
WASHINGTON (Reuters) - Researchers at Amgen found more mutations that show who will not be helped by its colon cancer drug Vectibix and said on Sunday the study shows companies can find efficient ways to find the right drugs for the right patients.
U.S. Medicare Panel to Weigh Prostate Treatments
WASHINGTON (Reuters) - At a time of growing debate over prostate cancer treatments, U.S. Medicare officials will take a closer look at radiation therapy and its ability to reduce deaths and side effects in men.